BioSyent Inc.

C$17.70As of Sun 8 Nov 2026, 12:00 UTC
TSXV:RXHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR 8.38%
Div yield 1.24%
ROE 23.65%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.70
PE TTM 20.72
TSR TTM 63.37%
Mkt cap C$200.2M
ROIC 24.56%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$18
2.66%
(37.29%)
Hold 2|6|4|11|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.21
0.20
0.22
0.22
7.81%
3.61%
0.02%
2.42%
Revenue$M
10.06
10.35
10.35
10.84
5.68%
3.65%
5.59%
11.95%
Peers (US$141.7M)
Cap (US$)
PE
146.0M
19.01x
145.5M
—
124.8M
1.968x
144.0M
4.986x
Capital
TTM
5Y
10Y
Leveragex
0.903
(1.028)
(0.812)
EBIT/Intx
1.548
0.292
0.214
Own earn%
18.25
(18.01)
(26.39)
Sh yield%
50.08
31.50
27.96
Owners
Insiders/Inst%
0.60
35.37
Short interest%
3.54
SBC / revenue%
0.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
28–36
$1 testx
0.2
Incr. ROIC%
8